A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement
Clinical trial NCT06402058 · UNKNOWN
Trial details
- NCT number
- NCT06402058
- Sponsor
- Samyang Biopharmaceuticals Corporation
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-10
- Primary completion
- 2025-01-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.